Irinotecan hydrochloride.
Wilkinson
K
K
D000972:Antineoplastic Agents, Phytogenic / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000451:nursing; D016903:Drug Monitoring / Q000451:nursing; D006801:Humans; D000077146:Irinotecan; D009503:Neutropenia / Q000097:blood / Q000139:chemically induced; D024802:Nurse's Role; D009730:Nursing Assessment; D010353:Patient Education as Topic; D018579:Patient Selection; D059004:Topoisomerase I Inhibitors
D000972:Antineoplastic Agents, Phytogenic; D059004:Topoisomerase I Inhibitors; D000077146:Irinotecan; D002166:Camptothecin